Literature DB >> 26186552

Comparative analysis of human mesenchymal stem cells from fetal-bone marrow, adipose tissue, and Warton's jelly as sources of cell immunomodulatory therapy.

Qiushi Wang1, Qiaoni Yang1, Zhe Wang1, Haixia Tong1, Liangyan Ma1, Yi Zhang1, Fengping Shan2, Yiming Meng2, Zhengwei Yuan1.   

Abstract

To characterize different tissue MSCs as sources of cell immunomodulatory therapy. Examined the effects of IFN-γ on WJ-MSC and their immunomodulatory function characteristics. We compared human fetal bone marrow (F-BM), adipose tissue (AT), and Warton's Jelly-derived MSCs (WJ-MSCs) for surface antigen expression, differentiation ability, proliferation capacity, clonality, tolerance for aging, gene expression, and whether IFN-γ affected WJ-MSC gene expression, as determined by real time quantitative PCR. Fifteen geneswere examined. We further assess WJ-MSCs-mediated immunomodulatory on peripheral blood mononuclear, stimulated by PHA, IL-2 and CD3Ab after 5 days of co-cultured in a 5:1 ratio (PBMC:MSCs). Examined the effect of WJ-MSCs on the Th1, Th2, Th17 cytokines production and Treg augument. MSCs from different tissues have similar levels of cell surface antigen expression and differentiation ability, while F-BM-MSCs and WJ-MSC had higher rates of cell proliferation and clonality than AD-MSCs. All 15 genes were expressed at similar levels in WJ-MSCs and AD-MSCs (P > 0.05). 9 genes were upregulated in WJ-MSCFor F-MSC, including IL-6, CXCL9, CXCL10, CXCL11, ICAM-1, IDO1, HLA-G5, SDF1A, and NOTCH were down expression, but VCAM-1 was lower expressionin WJ-MSCS. After IFN-γ treatment, 7 genes were upregulated in WJ-MSC, including chemokine ligands CXCL9, CXCL10 and CXCL11, and the adhesion protein VCAM1and ICAM1. Additionally, immunosuppressive factors, such as HLA-G and IDO were both increased. When cocultured with peripheral blood mononuclear, WJ-MSCs showed an immunosuppressive function by inhibit the proliferative response of Th1 and Th17 but augment Th2 and Treg. Primed WJ-MSCs by IFNγ caused a greater reduction in IFNγ and TNFα than untreated WJ-MSCs, also the effect on augument in Treg and inhibit Th17 (P < 0.01). Our results demonstrate that primitive F-BM-MSCs and WJ-MSCs have biological advantages as compared to adult cells, WJ-MSCs have a gene expression pattern similar to AT-MSCs but not F-BM MSCs, and that inflammatory stimuli regulate gene expression in WJ-MSCs. WJ-MSC showed the immunosuppressive function in co-cultured system with PBMC, and IFNγ can promoted the immunosuppressive function.

Entities:  

Keywords:  Wharton's jelly; adipose tissue; fetal bone marrow; gene expression; mesenchymal stem cells

Mesh:

Substances:

Year:  2016        PMID: 26186552      PMCID: PMC4962749          DOI: 10.1080/21645515.2015.1030549

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  43 in total

1.  Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells.

Authors:  Karin Stenderup; Jeannette Justesen; Christian Clausen; Moustapha Kassem
Journal:  Bone       Date:  2003-12       Impact factor: 4.398

2.  Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord.

Authors:  Hwai-Shi Wang; Shih-Chieh Hung; Shu-Tine Peng; Chun-Chieh Huang; Hung-Mu Wei; Yi-Jhih Guo; Yu-Show Fu; Mei-Chun Lai; Chin-Chang Chen
Journal:  Stem Cells       Date:  2004       Impact factor: 6.277

Review 3.  Mesenchymal stem cells as trophic mediators.

Authors:  Arnold I Caplan; James E Dennis
Journal:  J Cell Biochem       Date:  2006-08-01       Impact factor: 4.429

4.  Fetal BM-derived mesenchymal stem cells promote the expansion of human Th17 cells, but inhibit the production of Th1 cells.

Authors:  Zhenxing Guo; Cuiling Zheng; Zhenping Chen; Dongsheng Gu; Weiting Du; Jing Ge; Zhongchao Han; Renchi Yang
Journal:  Eur J Immunol       Date:  2009-10       Impact factor: 5.532

5.  Analysis of lymphocyte subpopulations in cerebrospinal fluid and peripheral blood in patients with multiple sclerosis and inflammatory diseases of the nervous system.

Authors:  C Oreja-Guevara; E Sindern; M Raulf-Heimsoth; J P Malin
Journal:  Acta Neurol Scand       Date:  1998-11       Impact factor: 3.209

6.  Immune regulatory properties of multipotent mesenchymal stromal cells: Where do we stand?

Authors:  Enio José Bassi; Carlos Alberto Mayora Aita; Niels Olsen Saraiva Câmara
Journal:  World J Stem Cells       Date:  2011-01-26       Impact factor: 5.326

7.  Adult human mesenchymal cells proliferate and migrate in response to chemokines expressed in demyelination.

Authors:  Claire M Rice; Neil J Scolding
Journal:  Cell Adh Migr       Date:  2010-04-03       Impact factor: 3.405

8.  Prevention of allogeneic fetal rejection by tryptophan catabolism.

Authors:  D H Munn; M Zhou; J T Attwood; I Bondarev; S J Conway; B Marshall; C Brown; A L Mellor
Journal:  Science       Date:  1998-08-21       Impact factor: 47.728

9.  Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation.

Authors:  Roland Meisel; Andree Zibert; Maurice Laryea; Ulrich Göbel; Walter Däubener; Dagmar Dilloo
Journal:  Blood       Date:  2004-03-04       Impact factor: 22.113

10.  IFN-gamma activation of mesenchymal stem cells for treatment and prevention of graft versus host disease.

Authors:  David Polchert; Justin Sobinsky; Gw Douglas; Martha Kidd; Ada Moadsiri; Eduardo Reina; Kristyn Genrich; Swati Mehrotra; Suman Setty; Brett Smith; Amelia Bartholomew
Journal:  Eur J Immunol       Date:  2008-06       Impact factor: 5.532

View more
  44 in total

Review 1.  The role of adipose stem cells in inflammatory bowel disease: From biology to novel therapeutic strategies.

Authors:  Francesco De Francesco; Maurizio Romano; Laura Zarantonello; Cesare Ruffolo; Daniele Neri; Nicolò Bassi; Antonio Giordano; Giacomo Zanus; Giuseppe A Ferraro; Umberto Cillo
Journal:  Cancer Biol Ther       Date:  2016-07-14       Impact factor: 4.742

2.  Wharton's Jelly Mesenchymal Stromal Cells from Human Umbilical Cord: a Close-up on Immunomodulatory Molecules Featured In Situ and In Vitro.

Authors:  Tiziana Corsello; Giandomenico Amico; Simona Corrao; Rita Anzalone; Francesca Timoneri; Melania Lo Iacono; Eleonora Russo; Giovanni Francesco Spatola; Maria Laura Uzzo; Mario Giuffrè; Martin Caprnda; Peter Kubatka; Peter Kruzliak; Pier Giulio Conaldi; Giampiero La Rocca
Journal:  Stem Cell Rev Rep       Date:  2019-12       Impact factor: 5.739

Review 3.  Exploring the roles of MSCs in infections: focus on bacterial diseases.

Authors:  Pasquale Marrazzo; Annunziata Nancy Crupi; Francesco Alviano; Laura Teodori; Laura Bonsi
Journal:  J Mol Med (Berl)       Date:  2019-02-07       Impact factor: 4.599

4.  Enhancing Mesenchymal Stromal Cell Potency: Inflammatory Licensing via Mechanotransduction.

Authors:  Max A Skibber; Scott D Olson; Karthik S Prabhakara; Brijesh S Gill; Charles S Cox
Journal:  Front Immunol       Date:  2022-07-06       Impact factor: 8.786

5.  Exosomes derived from umbilical cord mesenchymal stem cells protect cartilage and regulate the polarization of macrophages in osteoarthritis.

Authors:  Pengdong Li; Shuang Lv; Wenyue Jiang; Lihui Si; Baojian Liao; Guifang Zhao; Ziran Xu; Lina Wang; Jia Zhang; Haitao Wu; Qian Peng; Zhaohui Li; Ling Qi; Guangfan Chi; Yulin Li
Journal:  Ann Transl Med       Date:  2022-09

6.  Potency testing of mesenchymal stromal cell growth expanded in human platelet lysate from different human tissues.

Authors:  R Fazzina; P Iudicone; D Fioravanti; G Bonanno; P Totta; I G Zizzari; L Pierelli
Journal:  Stem Cell Res Ther       Date:  2016-08-25       Impact factor: 6.832

7.  Allogeneic Umbilical Cord-Derived Mesenchymal Stem Cells as a Potential Source for Cartilage and Bone Regeneration: An In Vitro Study.

Authors:  A Marmotti; S Mattia; F Castoldi; A Barbero; L Mangiavini; D E Bonasia; M Bruzzone; F Dettoni; R Scurati; G M Peretti
Journal:  Stem Cells Int       Date:  2017-11-16       Impact factor: 5.443

Review 8.  Regenerative Therapies in Dry Eye Disease: From Growth Factors to Cell Therapy.

Authors:  Antonio J Villatoro; Viviana Fernández; Silvia Claros; Cristina Alcoholado; Manuel Cifuentes; Jesús Merayo-Lloves; José A Andrades; José Becerra
Journal:  Int J Mol Sci       Date:  2017-10-28       Impact factor: 5.923

Review 9.  A paradigm shift in cell-free approach: the emerging role of MSCs-derived exosomes in regenerative medicine.

Authors:  Soudeh Moghadasi; Marischa Elveny; Heshu Sulaiman Rahman; Wanich Suksatan; Abduladheem Turki Jalil; Walid Kamal Abdelbasset; Alexei Valerievich Yumashev; Siavash Shariatzadeh; Roza Motavalli; Farahnaz Behzad; Faroogh Marofi; Ali Hassanzadeh; Yashwant Pathak; Mostafa Jarahian
Journal:  J Transl Med       Date:  2021-07-12       Impact factor: 5.531

Review 10.  Comparing the Immunomodulatory Properties of Bone Marrow, Adipose Tissue, and Birth-Associated Tissue Mesenchymal Stromal Cells.

Authors:  Philipp Mattar; Karen Bieback
Journal:  Front Immunol       Date:  2015-11-03       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.